Barrier disruption by coagulation FXIa.
作者信息
Wenzel Philip, Ruf Wolfram
机构信息
Johannes Gutenberg University Medical Center.
出版信息
Blood. 2024 Oct 24;144(17):1760-1762. doi: 10.1182/blood.2024026283.
Abstract
摘要
相似文献
1
Barrier disruption by coagulation FXIa.凝血因子XIa导致的屏障破坏
Blood. 2024 Oct 24;144(17):1760-1762. doi: 10.1182/blood.2024026283.
2
Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo.凝血因子 XI 在体外和体内调节血管内皮细胞的通透性和屏障功能。
Blood. 2024 Oct 24;144(17):1821-1833. doi: 10.1182/blood.2023022257.
3
Novel interaction of properdin and coagulation factor XI: Crosstalk between complement and coagulation.备解素与凝血因子XI的新型相互作用：补体与凝血之间的串扰
Res Pract Thromb Haemost. 2022 May 24;6(4):e12715. doi: 10.1002/rth2.12715. eCollection 2022 May.
4
Evidence for factor IX-independent roles for factor XIa in blood coagulation.凝血因子XIa在血液凝固中不依赖凝血因子IX的作用的证据。
J Thromb Haemost. 2013 Dec;11(12):2118-27. doi: 10.1111/jth.12435.
5
Interferences associated with the factor XIa inhibitors asundexian and milvexian in routine and specialized coagulation assays and their removal by activated charcoal-based adsorbents.在常规和特殊凝血检测中与凝血因子 XIa 抑制剂阿孙地昔和米尔维昔相关的干扰及其通过活性炭基吸附剂的去除
J Thromb Haemost. 2025 Sep;23(9):2819-2829. doi: 10.1016/j.jtha.2025.05.030. Epub 2025 Jun 9.
6
Synergy Between Tissue Factor and Exogenous Factor XIa in Initiating Coagulation.组织因子与外源性因子XIa在启动凝血过程中的协同作用。
Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2334-2345. doi: 10.1161/ATVBAHA.116.308186. Epub 2016 Oct 27.
7
Coagulation factor XI induces Ca response and accelerates cell migration in vascular smooth muscle cells via proteinase-activated receptor 1.凝血因子 XI 通过蛋白酶激活受体 1 诱导血管平滑肌细胞内钙离子响应并加速细胞迁移。
Am J Physiol Cell Physiol. 2019 Mar 1;316(3):C377-C392. doi: 10.1152/ajpcell.00426.2018. Epub 2018 Dec 19.
8
Role of platelets in regulating activated coagulation factor XI activity.血小板在调节激活的凝血因子 XI 活性中的作用。
Am J Physiol Cell Physiol. 2021 Mar 1;320(3):C365-C374. doi: 10.1152/ajpcell.00056.2020. Epub 2021 Jan 20.
9
Cross-Talk between the Complement Pathway and the Contact Activation System of Coagulation: Activated Factor XI Neutralizes Complement Factor H.补体途径与凝血接触激活系统的串扰：激活的因子 XI 中和补体因子 H。
J Immunol. 2021 Apr 15;206(8):1784-1792. doi: 10.4049/jimmunol.2000398.
10
Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of FXIa (Activated Factor XI).内皮细胞 PAI-1（纤溶酶原激活物抑制剂-1）可阻断凝血的内在途径，诱导 FXIa（活化因子 XI）的清除和降解。
Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1390-1401. doi: 10.1161/ATVBAHA.119.312619. Epub 2019 May 23.
本文引用的文献
1
Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo.凝血因子 XI 在体外和体内调节血管内皮细胞的通透性和屏障功能。
Blood. 2024 Oct 24;144(17):1821-1833. doi: 10.1182/blood.2023022257.
2
Targeting factor XI and factor XIa to prevent thrombosis.靶向因子 XI 和因子 XIa 以预防血栓形成。
Blood. 2024 Apr 11;143(15):1465-1475. doi: 10.1182/blood.2023020722.
3
Substrates, Cofactors, and Cellular Targets of Coagulation Factor XIa.凝血因子 XIa 的底物、辅因子和细胞靶标。
Semin Thromb Hemost. 2024 Oct;50(7):962-969. doi: 10.1055/s-0043-1764469. Epub 2023 Mar 20.
4
An update on factor XII-driven vascular inflammation.关于因子 XII 驱动的血管炎症的最新进展。
Biochim Biophys Acta Mol Cell Res. 2022 Jan;1869(1):119166. doi: 10.1016/j.bbamcr.2021.119166. Epub 2021 Oct 24.
5
Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice.凝血因子XI的药理学靶向作用可减轻低密度脂蛋白受体缺陷小鼠实验性动脉粥样硬化的发展。
J Thromb Haemost. 2021 Apr;19(4):1001-1017. doi: 10.1111/jth.15236. Epub 2021 Feb 10.
6
Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension.血小板定位型 FXI 在动脉高血压中促进血管凝血-炎症循环。
Sci Transl Med. 2017 Feb 1;9(375). doi: 10.1126/scitranslmed.aah4923.
7
Apolipoprotein E Receptor 2 Mediates Activated Protein C-Induced Endothelial Akt Activation and Endothelial Barrier Stabilization.载脂蛋白E受体2介导活化蛋白C诱导的内皮细胞Akt激活和内皮屏障稳定。
Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):518-24. doi: 10.1161/ATVBAHA.115.306795. Epub 2016 Jan 21.
8
Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus.组织因子途径抑制剂通过其羧基末端阻断血管生成。
Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):704-11. doi: 10.1161/ATVBAHA.111.243733. Epub 2012 Jan 5.
9
Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1.内源性和重组组织因子途径抑制物1对组织因子诱导信号传导的调节
Blood. 2005 Mar 15;105(6):2384-91. doi: 10.1182/blood-2004-09-3422. Epub 2004 Nov 18.
10
Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor.组织因子途径抑制剂通过与极低密度脂蛋白受体结合来抑制内皮细胞增殖。
J Biol Chem. 2001 Apr 13;276(15):12241-8. doi: 10.1074/jbc.M010395200. Epub 2001 Jan 17.
Zotero 插件